Health

NIH Funding Cuts Halt Alzheimer’s Research in Black Communities

The National Institutes of Health (NIH) has abruptly halted funding for several long-standing research projects, including studies focused on Alzheimer’s disease in Black communities, triggering a legal challenge and widespread concern among scientists and participants. The federal agency’s decision to terminate these grants has effectively ended years of data collection and raised alarm regarding the future of research aimed at addressing racial health disparities.

In Pittsburgh, a study aimed at understanding why Black Americans are twice as likely as their white peers to develop Alzheimer’s was cut in its final year. Researchers noted that the termination wasted more than $8 million in taxpayer funds that had already been spent. Beyond the financial loss, those involved in the project expressed concern over the damage done to the hard-earned trust of study participants, who may now never receive results from the brain tests and assessments they provided.

Roderick Blair, 70, who participated in the Pittsburgh study for four years, described the abandonment of the project as a betrayal. “The community will look like, ‘Oh, they came in here, they took all our stuff, they checked us out. Now they’re gonna leave us hanging,'” Blair said.

Health experts emphasize that trust in U.S. medical institutions within the Black community has historically been fragile, often citing the legacy of the Tuskegee study, which withheld syphilis treatment from Black men in the 1930s. La’Vette Wagner, the field coordinator for the Pittsburgh study, noted that the project had successfully overcome some of that skepticism, encouraging community members to discuss memory loss and dementia openly. According to the Alzheimer’s Association, more than half of Black Americans believe that significant memory loss is a natural part of aging, a misconception the study aimed to challenge.

However, the NIH stripped the Pittsburgh project of funding last year, characterizing the research as “not science,” according to the study’s researchers, despite it having undergone rigorous vetting by a community advisory board. Similar terminations have occurred nationwide. Negar Fani, a neuropsychologist at Emory University, had a five-year, $2.9 million project studying how racial discrimination impacts the brain and body of Black Americans terminated by the NIH in July. Like the Pittsburgh study, Fani’s grant was cut on the grounds that it was “not scientific” and “subjective,” even after the project had enrolled 66 of its target 220 participants.

In response to the cuts, a spokesperson for the Department of Health and Human Services (HHS) stated that “Massive amounts of DEI grants have failed to translate into better health outcomes for minority populations.” The spokesperson added that, following directives from the Trump administration, the NIH is shifting resources toward research described as more rigorous to help all Americans, including minority populations, live longer, healthier lives.

Data indicates that these funding shifts are widespread. A report from the Association of American Medical Colleges found that the NIH has awarded 2,000 fewer grants for multiyear studies—worth a total of $200 million—in the current period compared with 2025. Jill Rosenthal, director of public health policy at the Center for American Progress, characterized the trend as unprecedented, arguing that decisions are increasingly based on political considerations rather than peer review processes or evidence-based assessment.

The terminations have led to a growing body of legal action. Lead researchers from the Pittsburgh study, including Andrea Rosso and Ann Cohen, are among a group of scientists who have filed a lawsuit against the NIH and HHS. The litigation challenges the administration’s ongoing efforts to identify and halt medical grants that include descriptors such as “disparities,” “minority,” or “racial.”

For researchers like Cohen, who led a complementary Alzheimer’s risk study that was also halted after $5.2 million in spending, the primary concern remains the status of the data and physical samples collected. With the research stopped, findings remain “stuck on a shelf,” and the rapport built with the community may be difficult to recover. As Blair noted, “It’s going to take years to reestablish something that was moving pretty good.”

What's your take on this story? Share your perspective below.Join in

Join the discussion

0

Evelyn Price

Evelyn Price covers health news, medical research, public health developments, and wellness topics. She aims to present evidence-based information in clear language, helping readers understand important studies, health policies, and advances in medicine.
Back to top button